使用E-vita Open NEO行全主动脉弓置换加冷冻象鼻的1年结局
本研究基于Gangnam Severance主动脉登记处,纳入2021年4月至2023年3月连续167例使用E-vita Open NEO行全主动脉弓置换加冷冻象鼻的患者,分为急性主动脉夹层、慢性主动脉夹层和胸主动脉瘤三组。院内死亡率为1.8%,1年生存率为95.9%,1年免于任何主动脉手术为90.3%,免于计划外主动脉干预为92.0%。作者认为1年临床结局良好,但需长期随访评估耐久性。
要点
- 167例中急性主动脉夹层92例(55.1%)、慢性主动脉夹层20例(12.0%)、胸主动脉瘤55例(32.9%)。
- 院内死亡1.8%(n=3),卒中1.8%(n=3),脊髓损伤1.8%(n=3),因出血再次胸骨切开3.0%(n=5),各病理组间无显著差异。
- 中位随访198(37-373)天,1年生存率95.9%,1年免于任何主动脉手术90.3%,免于计划外主动脉干预92.0%。
核心结论
- 使用E-vita Open NEO行全主动脉弓置换加冷冻象鼻的1年临床结局良好,但需长期随访评估冷冻象鼻的耐久性。
研究设计与样本
- 队列研究,回顾Gangnam Severance主动脉登记处2021年4月至2023年3月行胸主动脉手术的患者,排除升主动脉置换、1或2部分主动脉弓置换、降主动脉置换及未使用冷冻象鼻的全主动脉弓置换。
- 最终连续纳入2021年4月至2023年3月因主动脉弓病变使用E-vita Open NEO行全主动脉弓置换加冷冻象鼻的患者167例,按病理分为急性主动脉夹层、慢性主动脉夹层和胸主动脉瘤三组。
主要发现
- 急性主动脉夹层92例(55.1%),慢性主动脉夹层20例(12.0%),胸主动脉瘤55例(32.9%)。
- 院内死亡率1.8%(n=3);卒中1.8%(n=3),脊髓损伤1.8%(n=3),因出血再次胸骨切开3.0%(n=5),各病理组间无显著差异。
- 中位随访198(37-373)天,1年生存率95.9%,1年免于任何主动脉手术90.3%,1年免于计划外主动脉干预92.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In this cohort study, we aimed to assess the 1-year clinical outcomes of using the E-vita Open NEO™ hybrid prosthesis for total arch replacement with frozen elephant trunk (FET) to repair extensive aortic pathologies. METHODS: We reviewed individuals who underwent thoracic aortic surgery between April 2021 and March 2023 from the Gangnam Severance Aortic Registry. Exclusion criteria included ascending aortic replacement, 1 or 2 partial arch replacement, descending aortic replacement and total arch replacement without an FET. Finally, all consecutive patients who underwent total arch replacement and FET with E-vita Open NEO for aortic arch pathologies between April 2021 and March 2023 were included in this cohort study. The patients were divided into 3 groups based on their pathology: acute aortic dissection, chronic aortic dissection and thoracic aortic aneurysm. The primary end point was in-hospital mortality. The secondary end points during the postoperative period comprised stroke, spinal cord injury and redo sternotomy for bleeding. Additionally, the secondary end points during the follow-up period included the 1-year survival rate, 1-year freedom from all aortic procedures and 1-year freedom from unplanned aortic interventions. RESULTS: The study included 167 patients in total: 92 patients (55.1%) with acute aortic dissection, 20 patients (12.0%) with chronic aortic dissection and 55 patients (32.9%) with thoracic aortic aneurysm. The in-hospital mortality was 1.8% (n = 3). Strokes occurred in 1.8% (n = 3) of the patients, spinal cord injury in 1.8% (n = 3) and redo sternotomy for bleeding was performed in 3.0% (n = 5). There were no significant differences between the pathological groups. The median follow-up period (quartile 1-quartile 3) was 198 (37-373) days, with 1-year survival rates of 95.9%. At 1 year, the freedom from all aortic procedures and unplanned aortic interventions were 90.3% and 92.0%, respectively. CONCLUSIONS: The 1-year clinical outcomes of total arch replacement with FET using the E-vita Open NEO were favourable. Long-term follow-up is required to evaluate the durability of the FET.
引用
- Kim CH, Kim TH, Lee H, et al. One-year outcomes of total arch replacement and frozen elephant trunk using the E-vita Open NEO. Eur J Cardiothorac Surg. 2024. PMID: 38238991. doi:10.1093/ejcts/ezae017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。